Histone Deacetylase Inhibitors in Cancer

Recent Prospectives of Anticancer Histone Deacetylase Inhibitors

Recent review on selective histone deacetylase inhibitors in cancer therapy

Design, synthesis, molecular docking study, and biological evaluation of salicylaldimine derivatives as potential histone deacetylases inhibitors (HDACi) and anticancer agents

HDAC as a cancer target: Various scaffolds based on HDAC inhibitors and an overview of their advances

Identification of Novel 4-Oxo-4H-chromen-Hydroxamic Acid Derivative Targeting Selected HDAC Isoforms

Coumarin based-histone deactylace HADC inhibitors

Design ,Synthesis, Insilco Study and Biological Evaluation of New Coumarin-Oxadiazole Derivatives as Potent Histone Deacetylase Inhibitors

Design, molecular docking, synthesis, and in vitro pharmacological evaluation of biomolecules-histone deacetylase inhibitors conjugates with carbohydrazide as a novel zinc-binding group

Novel Mannich Bases Derived from 2-Substituted Benzimidazole and (Thio)Hydantoin Moieties as Potent Histone Deacetylase 6 (HDAC6) Inhibitors